Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (5)

2022

  1. Parkinson's disease and diabetes mellitus: Common mechanisms and treatment repurposing

    Neural Regeneration Research, Vol. 17, Núm. 8, pp. 1652-1658

2021

  1. Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists

    Frontiers in Neuroendocrinology, Vol. 62

2014

  1. Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b

    Neurobiology of Disease, Vol. 69, pp. 206-214

  2. Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia

    Journal of Psychiatric Research, Vol. 51, Núm. 1, pp. 49-59

2013

  1. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease

    NeuroMolecular Medicine, Vol. 15, Núm. 2, pp. 295-309